Cerebras Systems Inc. (CBRS.US) — market event timeline
NashNova tracks 13 market events mentioning Cerebras Systems Inc. (CBRS.US) between 2026-06-04 and 2026-07-02, each with a dated one-line analysis of how the event relates to the asset.
- AI Inference Efficiency Gains Shake Memory Chip Stocks
The central player in this development: its inference chip validated through partnership with OpenAI, with dramatically lower inference costs driving a 19% single-day stock surge.
- AI Inference Chip Startup Etched Reaches $5 Billion Valuation with $1 Billion in Orders
Etched and Cerebras are direct competitors as AI chip startups, and capital enthusiasm in the sector mutually reinforces valuation expectations.
- ARK Added Over $48M in Cerebras Last Week While Trimming ~$70M in Alibaba
ARK's largest single buy of the week, adding approximately $48 million, directly benefiting from capital inflows.
- Cerebras Systems surges 18% over two days as multiple investment banks raise price targets
The central subject — multiple investment banks raised their price targets, directly driving an 18% cumulative stock price gain over two days.
- HBM Prices Keep Rising as Qualcomm, NVIDIA, and Cerebras Explore Memory-Reduced Architectures
Positions "no HBM usage" as a core selling point. If its HBM-free architecture gains customer validation, it could become the benchmark name for the memory-alternative route.
- OpenAI Releases GPT-5.6 Series Models; Flagship Sol Outperforms Claude Mythos in Benchmarks, Available Only to Government-Approved Partners
OpenAI explicitly announced Sol inference deployment through Cerebras starting July, with 750 tokens/s speed representing a key commercial order for its chip business.
- Cerebras Stock Drops 14% After First Earnings Report as Full-Year Gross Margin Guidance Falls Far Below NVIDIA
Directly impacted stock; first earnings report with gross margin guidance far below peers triggered a 14% sell-off.
- Cerebras Q1 Revenue Hits $193.4M with 94% YoY Growth, EPS Beats Estimates but Shares Slip 3% After Hours
Directly impacted stock; first post-IPO earnings beat on revenue but wider operating loss guidance for Q2 pressured shares after hours.
- WSJ: Altman's Personal Investment Portfolio Forms Web of Interests with OpenAI Deals
OpenAI's chip procurement deal directly boosted Cerebras' successful IPO, with Altman's stake appreciating over sixfold, making it one of the core targets in this story.
- Cerebras' First Earnings Report Since IPO Is Coming — Options Imply ~13% Stock Price Swing
Direct subject of the event — the first post-IPO earnings will test whether revenue growth can support the current valuation.
- Baseten Seeks $1.5B Raise at Up to $13B Valuation, Betting on Open-Source Model Inference Infrastructure
An AI inference chip company operating in the same inference track as Baseten; the fundraising momentum in the space serves as mutual validation.
- Wall Street Initiates Coverage on Cerebras with Price Targets Up to $300
Multiple investment banks simultaneously initiated coverage with premium price targets, directly impacting the stock's pricing anchor.
- Cerebras: In Talks with All AI Hardware Makers Except Nvidia
Wafer-scale AI inference chip maker actively building a hardware partnership network that bypasses Nvidia.
For research and information only — not investment advice.